
NanoRepro AG came to us with a clear goal: build a direct sales channel for medical self-tests, in parallel with the Amazon business and without putting the established pharmacy trade at risk. This is the journey we have walked together.
Months of partnership
Since Q1 2024, ongoing
Amazon revenue
12-month snapshot
Amazon ACOS
Down from 48% in 6 months
zuhausetest.de
D2C shop since Q3 2024

zuhausetest.de — the D2C shop of NanoRepro AG
At a glance
Client
NanoRepro AG
Listed, Marburg
Industry
Health & Diagnostics
Regulated
Scope
D2C + Marketplace
End-to-end
Partnership
Ongoing
Since Q1 2024
01 · The starting point
NanoRepro AG has been one of Germany's leading manufacturers of medical self-tests for decades. The products are sold through more than 8,000 pharmacies and drugstores across the DACH region — a strong, mature retail position. The online channel was a different story: Amazon listings existed, but without a strategic setup. There was no in-house D2C shop.
At the same time the market was changing: the COVID period had moved the medical self-test category into everyday consumer behavior. People who had never bought a rapid test before were suddenly used to it — and looking for products online. Exactly where NanoRepro had been underrepresented.
The state at project start (Q1 2024)
Amazon DE listings
11 ASINs
No A+ content, no Brand Store
Amazon Brand Registry
Not enrolled
No protection against hijackers
Average ACOS
≈ 48%
Inefficient keyword structure
D2C shop
Non-existent
No own webshop, no CRM
Content
Basic copy
No listings with full depth
* Figures anonymized and released for publication with the client's consent.
02 · The path
Phase 1
·Month 1–2
Before we touch anything, we understand. We audit every Amazon listing, check brand registration, analyze the competition in the self-test segment and define the audiences for the planned D2C shop.
Phase 2
·Month 3–5
Three channels run in parallel: Amazon relaunch, D2C shop launch and content build-up. Each channel has its own campaign logic — for Amazon compliance-first, for D2C trust-first.
Phase 3
·Month 6–12+
Once the foundations are running, we optimize iteratively. We bring ACOS down, expand the range on zuhausetest.de and start active retention work. In parallel we expand multi-marketplace.
03 · Strategic decisions
Amazon delivers volume but barely any customer data. D2C delivers less volume but full control over margin, customer relationship and brand perception. Both channels together form a more robust business model than either on its own.
Fast to build, scalable and sufficient for health compliance requirements. Magento would have been too heavy for the start, WooCommerce too brittle for a publicly listed company. Shopify offers the best compromise between speed and enterprise stability.
Amazon strictly regulates statements about health products. Any non-compliant phrasing risks ad rejection or worse: a listing block. We build trust through A+ content, advice articles and product imagery — not through aggressive promotional claims.
In the self-test segment, the bestsellers are disproportionately important. Better 5 products on page 1 than 20 on page 4. Once the core products perform reliably, we open up the breadth of the range.
04 · The work
Marketplace
New product imagery, keyword-optimized titles, structured bullet points and full A+ content for all 11 core ASINs.
D2C
Shopify shop with trust elements, FAQ, product landing pages and a full compliance structure for health products.
Marketplace
Dedicated brand experience on Amazon with product categories, advice content and cross-selling logic.
Content
FAQ, buying advice, product comparisons — content that builds trust without violating Amazon's health policies.
05 · Results
All figures based on Amazon Seller Central and Shopify Analytics. Snapshot of the first 12 months of the partnership (Q1 2024 – Q1 2025). The partnership continues today.
Amazon revenue
Q1 2024 vs. Q1 2025
ACOS reduction
Over 9 months
Active Amazon ASINs
Incl. variations and bundles
D2C conversion rate
zuhausetest.de, avg. 2024
Verified Amazon reviews
Organic, no incentives
BSR in core category
Self-tests / health
* Figures anonymized and released for publication with the client's consent.
06 · Challenges & learnings
Challenge
Several ad campaigns were rejected in the first weeks because the ad copy contained phrasing Amazon classifies as a medical claim — even when the wording was factually backed by the product itself. Our solution: a dedicated style guide for compliant ad copy, agreed with NanoRepro's regulatory department, and a template approach that pre-approves every new campaign launch.
Surprise
We had conservatively planned for a conversion rate of 1.2% in year one for zuhausetest.de. The actual average is 2.8%. The reason: customers buying directly from the manufacturer trust more — especially in the sensitive health segment. This validates the strategic decision for a dedicated D2C channel against marketplace dependency.
What we would do differently today
We launched the D2C shop with 14 products but minimal advisory content. The first months made it clear: especially in the self-test space, customers look for information first, then products. Had we produced FAQ, buying advice and editorial content one month before launch, D2C traffic would have been higher from day one. Learning: content is not a post-launch task.
SELECTNOIR understands not only Amazon and D2C — but also the regulatory requirements we are subject to as a publicly listed health brand. That is the difference between an agency and a real partner.
[Testimonial placeholder]
NanoRepro AG
07 · Next phase
The partnership with NanoRepro AG continues — and keeps evolving. Here is a look at the topics currently on our shared roadmap.
Amazon FR, IT and ES as the next stage — with localized listings.
Ordering portal for pharmacies with direct zuhausetest integration.
Email flows and customer retention via Shopify + Klaviyo.
Similar challenge?